Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy - Andreoni, M; Parisi, S G; Sarmati, L; Nicastri, E; Ercoli, L; Mancino, G; Sotgiu, G; Mannazzu, M; Trevenzoli, M; Tridente, G; Concia, E; Aceti, A (AIDS (London), 2000)
Keywords: Adult; Anti-HIV Agents - therapeutic use; CD4 Lymphocyte Count; Didanosine - therapeutic use; DNA, Viral - blood; Drug Therapy, Combination; Female; HIV Infections - drug therapy; HIV Protease Inhibitors - therapeutic use; HIV-1 - growth & development; HIV-1 - metabolism; Humans; Indinavir - therapeutic use; Male; Middle Aged; Prospective Studies; Proviruses - growth & development; Proviruses - metabolism; Reverse Transcriptase Inhibitors - therapeutic use; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral - blood; Stavudine - therapeutic use; Viremia - drug therapy